Filters

Teresa Nunes, Rita Machado, José F Rocha, Carlos Fernandes-Lopes, Raquel Costa, Leonel Torrão, Ana I Loureiro, Amílcar Falcão, Manuel Vaz-da-Silva, Lyndon Wright, Luis Almeida, Patricio Soares-da-Silva

Clinical therapeutics 2010;31(10):2258-71

Full Text

Abstract

Pharmacokinetic-pharmacodynamic modeling of levodopa in patients with advanced Parkinson disease.

Urszula Adamiak, Maria Kaldonska, Gabriela Klodowska-Duda, Elzbieta Wyska, Krzysztof Safranow, Monika Bialecka, Barbara Gawronska-Szklarz

Clinical neuropharmacology 2010;33(3):135-41

Full Text

Abstract

Replacing a dopamine agonist by the COMT-inhibitor tolcapone as an adjunct to L-dopa in the treatment of Parkinson's disease: a randomized, multicenter, open-label, parallel-group study.

Vincent Ries, Roland Selzer, Tobias Eichhorn, Wolfgang H Oertel, Karla Eggert

Clinical neuropharmacology 2010;33(3):142-50

Full Text

Abstract

Results: 1 – 11 / 11

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Benserazide""[mesh_terms]

Evaluation on the efficacy and safety of Chinese herbal medication Xifeng Dingchan Pill in treating Parkinson's disease: study protocol of a multicenter, open-label, randomized active-controlled trial.

Unchanged gastric emptying and visceral perception in early Parkinson's disease after a high caloric test meal.

Levodopa Impairs the Energy Metabolism of the Basal Ganglia In Vivo.

Occupational Mn parkinsonism: magnetic resonance imaging and clinical patterns following CaNa2-EDTA chelation.

Dopamine and human information processing: a reaction-time analysis of the effect of levodopa in healthy subjects.

Mucuna pruriens in Parkinson disease: A double-blind, randomized, controlled, crossover study.

Pharmacokinetics and Bioequivalence Study of Levodopa and Benserazide Tablets in Healthy Chinese Subjects Under Fasting and High-Fat Meal Conditions.

The effect of Madopar on the pharmacokinetics of ropinirole in healthy Chinese volunteers.

Pharmacokinetic-pharmacodynamic interaction between nebicapone and controlled-release levodopa/benserazide: a single-center, Phase I, double-blind, randomized, placebo-controlled, four-way crossover study in healthy subjects.

Pharmacokinetic-pharmacodynamic modeling of levodopa in patients with advanced Parkinson disease.

Replacing a dopamine agonist by the COMT-inhibitor tolcapone as an adjunct to L-dopa in the treatment of Parkinson's disease: a randomized, multicenter, open-label, parallel-group study.

Results for
""Benserazide""[mesh_terms]